Page 3 - Platform Randomised Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Platform randomised trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Platform Randomised Trial Today - Breaking & Trending Today

Parasite drug analysed as possible Covid treatment in UK trial

Parasite drug analysed as possible Covid treatment in UK trial
moneyweb.co.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneyweb.co.za Daily Mail and Mail on Sunday newspapers.

South Africa , United Kingdom , Chris Butler , University Of Oxford , European Medicines Agency , Community For Epidemic , World Health Organisation , Platform Randomised Trial , Pandemic Illnesses , ஒன்றுபட்டது கிஂக்டம் , கிறிஸ் பட்லர் , பல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் ,

Ivermectin to be investigated as possible Covid treatment in UK study

Ivermectin to be investigated as possible Covid treatment in UK study
biznews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biznews.com Daily Mail and Mail on Sunday newspapers.

South Africa , United Kingdom , Eli Schwarz , Katharine Gemmell , Nathan Geffen , Jarryd Neves , Chris Butler , University Of Oxford , European Medicines Agency , World Health Organization , Community For Epidemic , Professor Eli Schwarz , Platform Randomised Trial , Pandemic Illnesses , ஒன்றுபட்டது கிஂக்டம் , எலி ஸ்க்வார்ஸ் , க்யாத்ரிந் கெம்மல் , நாதன் கெஃப்ஃபெந் , கிறிஸ் பட்லர் , பல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் ,

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19

Share
Early treatment with inhaled budesonide shortens recovery time by a median of three days in patients with COVID-19 who are at higher risk of more severe illness and are treated in the community, finds Oxford University’s Platform Randomised Trial of Interventions against COVID-19 in Older People (PRINCIPLE) trial.
PRINCIPLE is the world’s largest Phase 3 platform randomised controlled trial to find clear evidence of an effective COVID-19 treatment for use in the community that can significantly shorten recovery time. As one of the UK Government’s national priority platform trials, findings from PRINCIPLE have potential to change how COVID-19 is treated in its early stages in non-hospital, community settings in the UK and internationally. ....

United Kingdom , Fiona Watt , Richard Hobbs , Mona Bafadhel , Chris Butler , Trial Steering Committee , United Kingdom Research , University Of Oxford , Oxford University Platform Randomised Trial Of Interventions , National Institute For Health Research , Therapeutics Task , Department Of Health , Oxford University Nuffield Department Of Medicine , Research Council , Oxford University , Platform Randomised Trial , Older People , United Kingdom Government , Chief Investigator , Professor Chris Butler , South Wales , Primary Care , Nuffield Department , Primary Care Health Sciences , United Kingdom Wide , Therapeutics Taskforce ,

Oxford study finds standard asthma medication improves recovery time in COVID-19 patients

Oxford study finds standard asthma medication improves recovery time in COVID-19 patients
Early treatment with inhaled budesonide could help high-risk patients
A study led by Oxford University researchers has found the inhaled asthma medication budesonide can shorten recovery time when administered early to high-risk COVID-19 patients.
Budesonide is being evaluated as part of Oxford University’s Platform Randomised Trial of Interventions against COVID-19 in Older People (PRINCIPLE), which is aiming to identify effective COVID-19 treatment for use in the community that can significantly shorten recovery time.
Inhaled budesonide – a type of corticosteroid medication – is commonly used to treat asthma and chronic obstructive pulmonary disease. ....

Oxford University Platform Randomised Trial Of Interventions , Oxford University , Platform Randomised Trial , Older People , ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் , பழையது மக்கள் ,

The FINANCIAL - Asthma Drug Shortens Recovery Time in COVID-19 Patients at Home

Share This
The FINANCIAL Early treatment with an asthma drug budesonide shortens recovery time in COVID-19 patients aged over 50 who are treated at home or in other community settings.
The Platform Randomised Trial of Interventions against COVID-19 in Older People (PRINCIPLE) trial is led by the University of Oxford. It is funded by UK Research and Innovation and the National Institute for Health Research (NIHR) through the COVID-19 Rapid Response rolling call.
It is the world’s largest Phase 3 platform randomised controlled trial to find clear evidence of an effective COVID-19 treatment for use in primary care that can significantly shorten recovery time. ....

United Kingdom , Fiona Watt , Richard Hobbs , Chris Butler , National Institute For Health Research , Therapeutics Task , United Kingdom Research , University Of Oxford , Connectivity National Core Study , Research Council , Platform Randomised Trial , Older People , National Institute , Health Research , Chief Investigator , Professor Richard Hobbs , Oxford University , Nuffield Department , Primary Care Health Sciences , Executive Chair , Medical Research Council , Professor Chris Butler , South Wales , Primary Care , United Kingdom Wide , Therapeutics Taskforce ,